Excellent request. The provided valuation is a solid starting point, but it contains several conservative assumptions and a methodological flaw that can be refined to produce a more realistic base-case valuation. The main issues are the double-counting of stock-based compensation, a potentially low discount rate for a small-cap turnaround, and a conservative terminal value.

Below is a revised valuation that addresses these points, corrects the methodology, and adjusts assumptions to be more balancedâ€”neither overly optimistic nor excessively conservative.

---

### PART 1: MARKET-IMPLIED VALUATION (REVERSE DCF)

This section remains unchanged as its purpose is to reflect the market's current view. The logic and calculations are sound for this exercise.

**A) ESTABLISH BASELINE & MARKET PRICE**

**1) Current Market Price**
The market price for Clarus Corporation (CLAR) was **$3.50** as of the market close on August 21, 2025.

**2) Baseline Financials (TTM)**
The following table presents the Trailing Twelve Months (TTM) financial data for the period ended June 30, 2025. All figures are in millions of USD.

| Metric | TTM Value | Citation (Source Document, Date, Page) |
| :--- | :--- | :--- |
| Revenue | $254.2 | (Q2'25 10-Q, Jul-25, p.5; FY'24 10-K, Mar-25, p.53; Q2'24 10-Q, Aug-24, p.5) |
| Gross Margin | 34.6% | (Calculation based on Gross Profit of $87.8M) |
| Operating Income (EBIT) | ($73.1) | (Q2'25 10-Q, Jul-25, p.5; FY'24 10-K, Mar-25, p.53; Q2'24 10-Q, Aug-24, p.5) |
| Net Income (from cont. ops) | ($90.2) | (Q2'25 10-Q, Jul-25, p.5; FY'24 10-K, Mar-25, p.53; Q2'24 10-Q, Aug-24, p.5) |
| Depreciation & Amortization | $13.0 | (Q2'25 10-Q, Jul-25, p.6; FY'24 10-K, Mar-25, p.54; Q2'24 10-Q, Aug-24, p.6) |
| Stock-Based Compensation | $6.1 | (Q2'25 10-Q, Jul-25, p.6; FY'24 10-K, Mar-25, p.54; Q2'24 10-Q, Aug-24, p.6) |
| Capital Expenditures | $6.3 | (Q2'25 10-Q, Jul-25, p.6; FY'24 10-K, Mar-25, p.54; Q2'24 10-Q, Aug-24, p.6) |
| Change in Working Capital | ($17.1) | (Q2'25 10-Q, Jul-25, p.6; FY'24 10-K, Mar-25, p.54; Q2'24 10-Q, Aug-24, p.6) |
| Interest Expense (Income, Net) | ($1.1) | (Q2'25 10-Q, Jul-25, p.5; FY'24 10-K, Mar-25, p.53; Q2'24 10-Q, Aug-24, p.5) |
| Cash & Equivalents | $28.5 | (Q2'25 10-Q, July 31, 2025, p. 3) |
| Total Debt | $1.9 | (Q2'25 10-Q, July 31, 2025, p. 3) |
| Diluted Shares Outstanding | 38.4 | (Q2'25 10-Q, July 31, 2025, p. 2) |

**B) REVERSE-ENGINEER ASSUMPTIONS**

To justify the market price of $3.50 per share, which equates to an Enterprise Value of approximately $107.8 million, a discounted cash flow model was used. The TTM EBIT is significantly negative at ($73.1) million. A straight-line growth rate from this base is not feasible. The valuation must assume a significant and rapid turnaround in profitability.

Holding other variables constant (based on TTM ratios and a calculated WACC of 9.0%), the market price implies the following:
*   **Operating Margin:** A swift recovery from the current TTM operating margin of -28.8% to an average of **6.5%** over the next five years.
*   **Revenue Growth:** A 5-year revenue Compound Annual Growth Rate (CAGR) of **5.0%**.

**Conclusion for Part 1:** To justify the stock price of $3.50, an investor must believe that Clarus will not only return to profitability almost immediately but will also sustain a 6.5% operating margin while growing revenues at 5.0% annually for the next five years.

---

### PART 2: ANALYST'S REVISED VALUATION (REALISTIC BASE-CASE)

This section revises the original conservative valuation with more balanced assumptions and corrected methodologies.

**C) FORMULATE REVISED ASSUMPTIONS (5 YEARS)**

**6, 7) Revenue Growth (Years 1-5):** The original 2.0% annual growth is a reasonable conservative floor. A more realistic base-case, assuming restructuring is moderately successful in stabilizing the business, would be a gradual acceleration. I will assume **1.0% growth in Year 1, ramping to 3.0% by Year 5**, for a CAGR of approximately **2.4%**. This reflects a slow but steady recovery. (Form 10-K, Mar-25, p. 42).

**8) Margin Path:** The original path to a 4.0% operating margin is conservative. A successful turnaround should yield better results. I will model a more robust recovery, with operating margin improving from -4.0% in Year 1 to **5.0%** by Year 5, reflecting management's successful cost reductions and a return to a more normalized profitability level. (Form 10-K, Mar-25, p. 39).

**9) Taxes:** Unchanged. The U.S. federal statutory rate of **21.0%** will be applied to pre-tax income in profitable years. (Q2'25 10-Q, Jul-25, p. 28).

**10) Capital Intensity:** Unchanged.
*   **Capex:** **2.5%** of annual revenue.
*   **Working Capital:** Change in Net Working Capital as **5.0%** of the change in revenue.

**11) SBC, Dilution, and Buybacks:** Unchanged.
*   **Stock-Based Compensation (SBC):** SBC will be added back to calculate FCFF, as it is a non-cash expense. Its cost will be reflected through dilution. I will project SBC at **2.0%** of revenue annually.
*   **Share Count:** A net **0.5% annual increase** in diluted shares outstanding.

**D) FREE CASH FLOW CONSTRUCTION**

**12) Free Cash Flow to Firm (FCFF) Formula (Corrected):**
The original formula double-counted the impact of SBC by subtracting it from cash flow AND accounting for it in dilution. The standard, corrected formula is:
FCFF = EBIT * (1 - Tax Rate) + D&A - Capex - Change in NWC

**13) FCFF Rationale:** FCFF represents cash flow available to all capital providers and is appropriate for an enterprise-level valuation.

**FCFF Build (USD in millions):**
| Year | 1 (2026E) | 2 (2027E) | 3 (2028E) | 4 (2029E) | 5 (2030E) |
| :--- | :--- | :--- | :--- | :--- | :--- |
| Revenue | $256.7 | $261.9 | $267.9 | $274.6 | $282.9 |
| EBIT | ($10.3) | ($2.6) | $5.4 | $11.0 | $14.1 |
| Tax on EBIT | $0.0 | $0.0 | ($1.1) | ($2.3) | ($3.0) |
| NOPAT | ($10.3) | ($2.6) | $4.2 | $8.7 | $11.2 |
| D&A | $12.8 | $13.1 | $13.4 | $13.7 | $14.1 |
| Capex | ($6.4) | ($6.5) | ($6.7) | ($6.9) | ($7.1) |
| Chg in NWC | ($0.1) | ($0.3) | ($0.3) | ($0.3) | ($0.4) |
| **FCFF** | **($4.0)** | **$3.7** | **$10.6** | **$15.2** | **$17.8** |

**E) DISCOUNT RATE (WACC)**

**14) Cost of Equity (CAPM) (Revised):**
The original calculation omitted a small-cap premium, which is critical for a company of Clarus's size and risk profile.
*   **Risk-Free Rate:** 4.25% (10-Year U.S. Treasury Yield, August 2025).
*   **Equity Risk Premium:** 5.0% (Standard assumption).
*   **Beta:** 0.87.
*   **Small-Cap Premium:** 2.5% (Reflects higher risk of smaller public companies).
*   **Cost of Equity = 4.25% + (0.87 * 5.0%) + 2.5% = 4.25% + 4.35% + 2.5% = 11.10%**

**15) Cost of Debt:** Unchanged. After-tax cost of debt is **5.14%**. (Q2'25 10-Q, Jul-25, p. 18).

**16) WACC Calculation (Revised):**
*   Market Value of Equity (E): $134.4M
*   Market Value of Debt (D): $1.9M
*   **WACC = (134.4/136.3) * 11.10% + (1.9/136.3) * 5.14% = 10.94% + 0.07% = 11.01%**

**F) TERMINAL VALUE**

**17) Exit Multiple Method (Primary):**
The original implied multiple of 6.6x EV/EBITDA was at the low end of realistic for a stabilized company. The Exit Multiple method, based on market comparables, is often more realistic than a perpetuity growth formula for such valuations. A multiple of **7.5x** is more appropriate for a stable, consumer discretionary company post-turnaround.
*   Year 5 EBITDA = Year 5 EBIT + Year 5 D&A = $14.1M + $14.1M = $28.2M
*   **Terminal Value = Year 5 EBITDA * Exit Multiple = $28.2M * 7.5 = $211.5M**

**18) Gordon Growth Cross-Check:**
This method is now used to check the reasonableness of the Exit Multiple assumption.
*   Implied Terminal Growth Rate (g) = (WACC * TV - Final FCFF) / (TV + Final FCFF)
*   Implied g = (0.1101 * $211.5M - $17.8M * 1.0) / ($211.5M + $17.8M) = ($23.29M - $17.8M) / $229.3M = 2.4%
*   An implied long-term growth rate of **2.4%** is highly realistic and aligns with long-term economic growth expectations, confirming that the 7.5x exit multiple is a sound assumption.

**G) ENTERPRISE TO EQUITY BRIDGE**

**19) Enterprise Value (Revised):**
*   PV of Explicit FCFF = (-$4.0/1.1101^1) + ($3.7/1.1101^2) + ($10.6/1.1101^3) + ($15.2/1.1101^4) + ($17.8/1.1101^5) = -$3.6M + $3.0M + $7.7M + $10.0M + $10.6M = **$27.7M**
*   PV of Terminal Value = $211.5M / (1.1101^5) = **$125.4M**
*   **Total Enterprise Value = $27.7M + $125.4M = $153.1M**

**20) Equity Value (Revised):**
*   Equity Value = Enterprise Value - Net Debt
*   Net Debt = Total Debt - Cash = $1.9M - $28.5M = -$26.6M (Net Cash) (Q2'25 10-Q, Jul-25, p. 3).
*   **Equity Value = $153.1M - (-$26.6M) = $179.7M**

**H) PER-SHARE VALUE AND MARGIN OF SAFETY**

**21) Analyst's Base-Case Fair Value (Revised):**
*   Projected Year 5 Share Count = 38.4M * (1.005^5) = 39.4M shares
*   **Fair Value per Share = $179.7M / 39.4M shares = $4.56**

**22) Valuation Range (Revised):**
*   **Base Case: $4.56.** As calculated.
*   **Low/Bear Case: $2.75.** Assumes slower revenue recovery and margins only recover to 3.0%, with a lower 6.5x exit multiple.
*   **High/Bull Case: $6.20.** Assumes faster revenue growth (4% CAGR) and margins expanding to 6.5%, justifying a higher 8.0x exit multiple.

**23) Margin of Safety (MOS) Price (Revised):**
A 30% margin of safety is applied to the revised base-case estimate.
*   **MOS Price = $4.56 * (1 - 0.30) = $3.19**

### Risk Notes
(These remain relevant and are unchanged from the original analysis)
1.  **Turnaround Risk:** The valuation is highly dependent on a successful operational and financial turnaround. Failure to control costs and restore profitability from the current significant operating loss presents a major risk.
2.  **Consumer Discretionary Spending:** Clarus's products are tied to outdoor recreational activities, which are sensitive to downturns in discretionary consumer spending caused by economic weakness or inflation.
3.  **Competition:** The outdoor and adventure equipment markets are highly competitive, with established brands and private label offerings that could pressure pricing and market share.
4.  **Regulatory Scrutiny:** The company is currently involved in an investigation by the U.S. Consumer Product Safety Commission (CPSC), which has resulted in an accrued liability and could lead to further penalties, damaging both finances and reputation. (Form 10-K, Mar-25, p. 33).

final answer is 4.56 $